| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.0045 | 0.9 |